Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details


		Treatment Name:		Study of a Retroviral Replicating Vector (Tocagen Toca 511) to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

		Phase:		Phase 1

		Treatment ID#:		2033

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		07/16/2012

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma Oligodendroglioma High Grade Recurrent Malignant Pediatric Brain Tumors


		Comments:

		Treatment Type:		Surgery Gene Therapy

		Contact:		Dr.Tom MikKelsen MD, FRCP(C) Co-Director Henry Ford Hospital Hermelin Brain Tumor Center E&R3096 Henry Ford Hospital 2799 West Grand Blvd Detroit, MI 48202- USA Phone: 313 916-8641 Fax: 313 916-9855 E-mail: nstom@neuro.hfh.edu Website: www.henryfordhealth.org/body.cfm?id=38441&action=detail&ref=968

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment